Combating Child Malnutrition and Disease in Nigeria
Innovative health strategies improve child survival in Nigeria through integrated Vitamin A and malaria prevention.
Olusola Oresanya, Olujide Arije, Jesujuwonlo Fadipe, Kunle Rotimi, Abimbola Phillips, Kolawole Maxwell, Emmanuel Shekarau, Nneka Onwu, Eva S. Bazant
― 5 min read
Table of Contents
Insub-Saharan Africa, many children face serious health risks, especially before reaching the age of five. Despite some improvements in child survival rates, one in every thirteen children still faces significant health dangers, particularly due to infectious diseases like malaria and Malnutrition. Nigeria stands out as a significant contributor to the number of under-five fatalities. To tackle these issues, it's essential to focus on effective Health Interventions that improve children's health and nutritional status.
The Role of Vitamin A Supplementation
A critical strategy to combat malnutrition in children is Vitamin A supplementation (VAS). Research shows that providing Vitamin A to children ages 6 to 59 months can notably reduce sickness and death rates. However, in Nigeria, less than half of eligible children receive this vital nutrient. The access to Vitamin A is particularly low in northern Nigeria, raising concerns about health inequalities.
To improve VAS delivery, some countries have adopted community-based distribution methods that align with local customs. One innovative approach is using Seasonal Malaria Chemoprevention (SMC) campaigns as a platform for distributing Vitamin A. This method involves providing children with specific medicines to prevent malaria during its peak transmission season.
The Integrated Approach to SMC and VAS
In 2021, a pilot study tested the combined delivery of SMC and VAS in Bauchi State, Nigeria. This state has alarming rates of malnutrition and was chosen for testing new health strategies. The pilot aimed to understand how integrating Vitamin A into existing SMC programs could increase Coverage and ultimately save lives.
The SMC method gives children a three-day treatment to ward off malaria. Community volunteers, known as drug distributors, play a crucial role in reaching children in their neighborhoods. By combining SMC with Vitamin A supplementation, the campaign aimed to address two major health issues simultaneously.
Study Area and Population
The study took place in two distinct areas of Bauchi State: Giade, a rural location, and Katagum, an urban center. With large populations of children under five, these areas were suitable for testing the effectiveness of the integrated health campaign. Given the high rates of malnutrition in Bauchi, the need for effective interventions is evident.
Implementation of SMC-VAS
The SMC program consists of distributing malaria preventive drugs to children aged 3 to 59 months. In the new integrated approach, eligible children also received Vitamin A supplements. Community drug distributors were trained to ensure they provided both treatments correctly. The campaign was conducted over four SMC cycles, each covering a specific malaria transmission season.
In the fourth cycle, the community drug distributors administered both the SMC drugs and Vitamin A in a door-to-door manner. This strategy aimed to improve access and ensure that no child missed out on receiving vital health interventions.
Costs Involved
An essential part of the study was analyzing costs associated with the integrated SMC and VAS campaign. The costs were divided into various categories, such as distribution expenses, drug costs, training, supplies, and labor. The total costs for the stand-alone SMC campaign were significantly less than those for the SMC-VAS integrated approach.
During the campaign, most of the costs came from distribution and the price of the drugs themselves. Interestingly, even though integrating Vitamin A increased costs, the additional expense per child was minimal. This efficiency suggests that combining these health interventions could be a cost-effective solution for improving child health.
Coverage and Accessibility
In terms of coverage, the integrated approach proved effective. More children received treatment during the SMC-VAS campaign compared to the SMC alone. By integrating Vitamin A distribution into existing SMC campaigns, the total number of children receiving both treatments increased, which speaks volumes about finding innovative ways to improve public health.
The study also found that the costs per child for receiving just SMC and those for the combined treatment of SMC and Vitamin A were both reasonable. This emphasizes the financial feasibility of adding Vitamin A to the routine SMC program.
Sensitivity Analysis
To ensure the reliability of the cost analysis, a sensitivity analysis was conducted. This process involved examining how changes in specific cost factors might impact the overall cost per child. The analysis highlighted distribution costs as a significant factor, reinforcing the idea that efficient distribution methods are crucial to the success of health interventions.
Findings and Implications
The findings of this study suggest that incorporating Vitamin A into SMC campaigns is not only beneficial for children's health but also economically viable. The nominal additional cost indicates that public health officials should consider this integrated approach seriously. Implementing Vitamin A alongside malaria preventive measures could lead to better nutritional status and reduced cases of malaria among vulnerable children.
The study also mentioned that while the upfront costs for training and materials could be higher, these were expected to decrease over time as the process becomes routine. This ongoing cost reduction could further enhance the sustainability of the integrated health intervention.
Study Limitations
Despite its promising findings, the study had some limitations. It focused only on two cycles of health campaigns, one with VAS integration and the other without. This narrow scope means that the overall cost per child over multiple SMC cycles remains unclear. Furthermore, the analysis did not take into account the costs incurred by parents or guardians involved in the campaigns.
Conclusion
Ultimately, integrating Vitamin A supplementation with seasonal malaria chemoprevention can be a smart move for public health. It offers an efficient way to address two major health concerns for children in Nigeria while keeping costs manageable. As health officials look for ways to improve child health outcomes, this innovative strategy could hold the key to ensuring that more children receive the care they need.
With serious efforts to enhance access and coverage for preventive health services, we can make strides toward reducing child morbidity and mortality rates in regions where they are needed the most. After all, a healthy child today means a brighter future tomorrow—just think of all the potential soccer stars and world leaders!
Original Source
Title: A cost analysis comparing Seasonal Malaria Chemoprevention with and without Vitamin A Supplementation among under-5 children in Nigeria
Abstract: BackgroundChild mortality in Nigeria, significantly affected by malaria and malnutrition, remains a public health concern in the country. Seasonal Malaria Chemoprevention (SMC) and Vitamin A supplementation (VAS) are effective interventions that can be delivered through integrated health campaigns to reduce this mortality. This study assesses the cost implications of integrating these two interventions among under-5 children in Northeast Nigeria. MethodsA cost analysis compared standalone SMC (Cycle 1 in July 2021) with SMC-VAS integrated campaign (Cycle 4 in October 2023) in two Local Government Areas (LGAs) in Bauchi State. The number of children reached by the SMC-only campaign was 168,820 and for the SMC+Vit A campaign, the number was 170,681. Data collection utilized a mixed-methods approach, drawing from primary and secondary sources, including programmatic, financial, and coverage records. Costs were categorized into distribution, Sulphadoxine-Pyrimethamine plus Amodaiquine (SPAQ) for SMC, Vitamin A, training, supplies, meetings, labor, supervision, and social mobilization costs. Sensitivity analyses evaluated the effect of a 10% fluctuation in the costs of distribution, labor, SPAQ, and supplies on the cost per child. ResultsThe total cost for the SMC standalone campaign was US$158,934, and the SMC-VAS integration was US$186,426. Distribution and drug costs were the largest contributors in the integrated and SMC-only campaign. The SMC-only cost per child was $0.94 and $1.18 when eligible children received both SMC and VAS. The integration of VAS into the SMC campaign cycle incurred an additional US$27,492 over Cycle 1 cost (US$186,426 - US$158,934). Fluctuations in distribution costs were the most influential component of the cost per child. ConclusionIntegrating VAS with SMC campaigns increases the cost by US$0.24 per child, a modest increment considering the potential health benefits. The results support the feasibility of this integration, in terms of cost, to combat child mortality from malaria and malnutrition in Nigeria. Further research is recommended to explore the cost-effectiveness of this integrated distribution model.
Authors: Olusola Oresanya, Olujide Arije, Jesujuwonlo Fadipe, Kunle Rotimi, Abimbola Phillips, Kolawole Maxwell, Emmanuel Shekarau, Nneka Onwu, Eva S. Bazant
Last Update: 2024-12-01 00:00:00
Language: English
Source URL: https://www.medrxiv.org/content/10.1101/2024.12.01.24318264
Source PDF: https://www.medrxiv.org/content/10.1101/2024.12.01.24318264.full.pdf
Licence: https://creativecommons.org/publicdomain/zero/1.0/
Changes: This summary was created with assistance from AI and may have inaccuracies. For accurate information, please refer to the original source documents linked here.
Thank you to medrxiv for use of its open access interoperability.